Proteomic Analysis Reveals Significant Elevation of Heat Shock Protein 70 in Patients with Chronic Heart Failure Due to Arrhythmogenic Right Ventricular Cardiomyopathy

Overview

Journal Mol Cell Biochem

Publisher Springer

Specialty Biochemistry

Date 2009 Jun 23

PMID 19543852

Citations 23

Authors

Ying-Jie Wei

Yin-Xia Huang

Ya Shen

Chuan-Jue Cui

Xiao-Ling Zhang

Hao Zhang

Sheng-Shou Hu

Affiliations

Soon will be listed here.

Abstract

As proteins are the ultimate biological determinants of phenotype of disease, we screened altered proteins associated with heart failure due to arrhythmogenic right ventricular cardiomyopathy (ARVC) to identify biomarkers potential for rapid diagnosis of heart failure. By 2-dimensional gel electrophoresis and mass spectrometry, we identified five commonly altered proteins with more than 1.5 fold changes in eight ARVC failing hearts using eight non-failing hearts as reference. Noticeably, one of the altered proteins, heat shock protein 70 (HSP70), was increased by 1.64 fold in ARVC failing hearts compared with non-failing hearts. The increase of cardiac HSP70 was further validated by Western blot, immunochemistry, and enzyme-linked immunosorbent assay (ELISA) in failing hearts due to not only ARVC, but also dilated (DCM, n = 18) and ischemic cardiomyopathy (ICM, n = 8). Serum HSP70 was also observed to be significantly increased in heart failure patients derived from the three forms of cardiomyopathies. In addition, we observed hypoxia/serum depletion stimulation induced significantly elevation of intracellular and extracellular HSP70 in cultured neonatal rat cardiomyocytes. For the first time to our knowledge, we revealed and clearly demonstrated significant up-regulation of cardiac and serum HSP70 in ARVC heart failure patients. Our results indicate that elevated HSP70 is the common feature of heart failure due to ARVC, DCM, and ICM, which suggests that HSP70 may be used as a biomarker for the presence of heart failure due to cardiomyopathies of different etiologies and may hold diagnostic/prognostic potential in clinical practice.

Citing Articles

In Vivo Approaches to Understand Arrhythmogenic Cardiomyopathy: Perspectives on Animal Models.

Risato G, Branas Casas R, Cason M, Bueno Marinas M, Pinci S, De Gaspari M Cells. 2024; 13(15).

PMID: 39120296 PMC: 11311808. DOI: 10.3390/cells13151264.

Heat Shock Protein 70 Constitutes a Promising Novel Biomarker in Differential Diagnosis between Takotsubo Syndrome and Non-ST-Segment Elevation Myocardial Infarction.

Demirel O, Paar V, Tolnai P, Topf A, Hoppe U, Lichtenauer M J Clin Med. 2024; 13(14).

PMID: 39064192 PMC: 11277720. DOI: 10.3390/jcm13144152.

Arrhythmogenic Cardiomyopathy: from Preclinical Models to Genotype-phenotype Correlation and Pathophysiology.

Fan X, Yang G, Duru F, Grilli M, Akin I, Zhou X Stem Cell Rev Rep. 2023; 19(8):2683-2708.

PMID: 37731079 PMC: 10661732. DOI: 10.1007/s12015-023-10615-0.

Advances in Ion Channel, Non-Desmosomal Variants and Autophagic Mechanisms Implicated in Arrhythmogenic Cardiomyopathy.

Li K, Jiang Y, Zeng Y, Zhou Y Curr Issues Mol Biol. 2023; 45(3):2186-2200.

PMID: 36975511 PMC: 10047275. DOI: 10.3390/cimb45030141.

Traditional Chinese Medicine Targeting Heat Shock Proteins as Therapeutic Strategy for Heart Failure.

Wang Y, Wu J, Wang D, Yang R, Liu Q Front Pharmacol. 2022; 12:814243.

PMID: 35115946 PMC: 8804377. DOI: 10.3389/fphar.2021.814243.

References

McGregor E, Dunn M . Proteomics of heart disease. Hum Mol Genet. 2003; 12 Spec No 2:R135-44. DOI: 10.1093/hmg/ddg278. View

Zhu W, Chen J, Cong X, Hu S, Chen X . Hypoxia and serum deprivation-induced apoptosis in mesenchymal stem cells. Stem Cells. 2005; 24(2):416-25. DOI: 10.1634/stemcells.2005-0121. View

Kawana K, Miyamoto Y, Tanonaka K, Yoshida H, Takahashi M, Takeo S . Cytoprotective mechanism of heat shock protein 70 against hypoxia/reoxygenation injury. J Mol Cell Cardiol. 2000; 32(12):2229-37. DOI: 10.1006/jmcc.2000.1250. View

Boheler K, Volkova M, Morrell C, Garg R, Zhu Y, Margulies K . Sex- and age-dependent human transcriptome variability: implications for chronic heart failure. Proc Natl Acad Sci U S A. 2003; 100(5):2754-9. PMC: 151413. DOI: 10.1073/pnas.0436564100. View

Crowther J . ELISA. Theory and practice. Methods Mol Biol. 1995; 42:1-218. DOI: 10.1385/0-89603-279-5:1. View

Barrans J, Allen P, Stamatiou D, Dzau V, Liew C . Global gene expression profiling of end-stage dilated cardiomyopathy using a human cardiovascular-based cDNA microarray. Am J Pathol. 2002; 160(6):2035-43. PMC: 1850841. DOI: 10.1016/S0002-9440(10)61153-4. View

Dybdahl B, Slordahl S, Waage A, Kierulf P, Espevik T, Sundan A . Myocardial ischaemia and the inflammatory response: release of heat shock protein 70 after myocardial infarction. Heart. 2005; 91(3):299-304. PMC: 1768748. DOI: 10.1136/hrt.2003.028092. View

Vasan R . Biomarkers of cardiovascular disease: molecular basis and practical considerations. Circulation. 2006; 113(19):2335-62. DOI: 10.1161/CIRCULATIONAHA.104.482570. View

Arab S, Gramolini A, Ping P, Kislinger T, Stanley B, Van Eyk J . Cardiovascular proteomics: tools to develop novel biomarkers and potential applications. J Am Coll Cardiol. 2006; 48(9):1733-41. DOI: 10.1016/j.jacc.2006.06.063. View

10.

Knowlton A, Kapadia S, Torre-Amione G, Durand J, Bies R, Young J . Differential expression of heat shock proteins in normal and failing human hearts. J Mol Cell Cardiol. 1998; 30(4):811-8. DOI: 10.1006/jmcc.1998.0646. View

11.

Sen-Chowdhry S, Syrris P, Ward D, Asimaki A, Sevdalis E, McKenna W . Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/cardiomyopathy provides novel insights into patterns of disease expression. Circulation. 2007; 115(13):1710-20. DOI: 10.1161/CIRCULATIONAHA.106.660241. View

12.

Neglia D, Michelassi C, Trivieri M, Sambuceti G, Giorgetti A, Pratali L . Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction. Circulation. 2002; 105(2):186-93. DOI: 10.1161/hc0202.102119. View

13.

Yung C, Halperin V, Tomaselli G, Winslow R . Gene expression profiles in end-stage human idiopathic dilated cardiomyopathy: altered expression of apoptotic and cytoskeletal genes. Genomics. 2004; 83(2):281-97. DOI: 10.1016/j.ygeno.2003.08.007. View

14.

Page B, Young R, Iyer V, Suzuki G, Lis M, Korotchkina L . Persistent regional downregulation in mitochondrial enzymes and upregulation of stress proteins in swine with chronic hibernating myocardium. Circ Res. 2007; 102(1):103-12. DOI: 10.1161/CIRCRESAHA.107.155895. View

15.

Heinke M, WHEELER C, Chang D, Einstein R, Dunn M, Dos Remedios C . Protein changes observed in pacing-induced heart failure using two-dimensional electrophoresis. Electrophoresis. 1998; 19(11):2021-30. DOI: 10.1002/elps.1150191122. View

16.

Jeyaseelan R, Poizat C, Baker R, Abdishoo S, Isterabadi L, Lyons G . A novel cardiac-restricted target for doxorubicin. CARP, a nuclear modulator of gene expression in cardiac progenitor cells and cardiomyocytes. J Biol Chem. 1997; 272(36):22800-8. DOI: 10.1074/jbc.272.36.22800. View

17.

Lainscak M, von Haehling S, Anker S . Natriuretic peptides and other biomarkers in chronic heart failure: from BNP, NT-proBNP, and MR-proANP to routine biochemical markers. Int J Cardiol. 2009; 132(3):303-11. DOI: 10.1016/j.ijcard.2008.11.149. View

18.

Corbett J, Why H, WHEELER C, Richardson P, Archard L, Yacoub M . Cardiac protein abnormalities in dilated cardiomyopathy detected by two-dimensional polyacrylamide gel electrophoresis. Electrophoresis. 1998; 19(11):2031-42. DOI: 10.1002/elps.1150191123. View

19.

Zhu J, Quyyumi A, Wu H, Csako G, Rott D, Zalles-Ganley A . Increased serum levels of heat shock protein 70 are associated with low risk of coronary artery disease. Arterioscler Thromb Vasc Biol. 2003; 23(6):1055-9. DOI: 10.1161/01.ATV.0000074899.60898.FD. View

20.

Basso C, Corrado D, Marcus F, Nava A, Thiene G . Arrhythmogenic right ventricular cardiomyopathy. Lancet. 2009; 373(9671):1289-300. DOI: 10.1016/S0140-6736(09)60256-7. View